BPC-157 is based on a protein fragment that naturally exists in human gastric juice, but the version sold as a supplement or used in clinics is entirely synthetic, manufactured in a laboratory. That distinction matters more than it might seem, because the lab-made peptide and the naturally occurring protein it comes from are not the same thing.
Where BPC-157 Comes From
Your stomach produces a larger protein called BPC (Body Protection Compound) as part of its normal digestive chemistry. BPC-157 is a specific 15-amino-acid sequence pulled from that protein, with the chain GEPPPGKPADDAGLV. In its natural setting inside gastric juice, this protein plays a role in protecting and repairing the stomach lining, which is why researchers became interested in it in the first place. The native protein is remarkably stable in the harsh acidic environment of the stomach, surviving intact for more than 24 hours.
So in a strict sense, the sequence that defines BPC-157 does occur in nature, inside your own body. But nobody is extracting it from gastric juice and bottling it. Every product labeled BPC-157 is a synthetic replica of that fragment, built from scratch using standard peptide synthesis techniques. One major manufacturer, Diagen in Slovenia, produces it at 99% purity as measured by laboratory analysis.
Why “Natural Origin” Doesn’t Mean Natural Product
Calling BPC-157 “natural” is a bit like calling synthetic insulin natural because the human body produces insulin. The molecular structure may be identical or very close to what your body makes, but the manufacturing process is purely chemical. This is a common pattern in peptide therapeutics: researchers identify a useful molecule in the body, then reproduce it in a lab so it can be studied and, potentially, used as a treatment.
The distinction carries real consequences. When a peptide is isolated from its biological context and injected or swallowed in concentrated form, it doesn’t necessarily behave the way it does inside the stomach lining. Your body produces BPC as part of a complex system with built-in feedback loops. A synthetic version delivered at higher concentrations, through different routes, may interact with the body differently. The FDA has specifically noted concerns about immunogenicity (the chance your immune system could react against the peptide) and impurities that can form during synthesis.
What BPC-157 Does in the Body
The reason BPC-157 has attracted so much attention, despite being unapproved, is its effects on blood vessel growth and tissue repair in animal studies. It triggers the formation of new blood vessels by boosting nitric oxide production, which widens blood vessels and encourages new capillary growth. It also stimulates cells called fibroblasts, which lay down the structural framework for healing tissue. These effects have made it especially popular among athletes and people recovering from tendon or ligament injuries.
One interesting wrinkle: many substances that promote new blood vessel growth also carry a risk of fueling tumor growth. BPC-157 appears to work differently. Animal research shows it actually suppresses uncontrolled cell proliferation and counters tumor-promoting pathways, even while encouraging normal tissue repair. That said, this has only been demonstrated in preclinical models, not in human trials.
No Approved Human Use Exists
There is no FDA-approved indication for BPC-157, for any condition, in any form. In September 2023, the FDA placed BPC-157 in its Category 2 list of bulk drug substances that raise significant safety concerns. This classification means commercial compounding pharmacies can no longer legally prepare it for patients. The agency’s reasoning was straightforward: there is little to no safety data for the routes people actually use it (injection, oral capsules), and the risks from peptide impurities and immune reactions are not well understood.
The World Anti-Doping Agency also prohibits BPC-157 at all times, both in and out of competition. It falls under the S0 category covering non-approved substances, alongside other drugs that lack regulatory approval for human therapeutic use. Athletes subject to drug testing face sanctions for using it regardless of their reason.
The Gap Between Animal Data and Human Evidence
Nearly everything known about BPC-157’s healing properties comes from studies in rats and mice. These studies show genuinely impressive results for tendon repair, gut healing, and wound recovery. But the leap from rodent models to human medicine is notoriously unreliable. Many compounds that work beautifully in animal studies fail or cause unexpected problems in people.
Despite this evidence gap, BPC-157 use among clinicians and athletes is growing. It is widely available through online peptide vendors and some medical practices that operate outside the compounding pharmacy framework. The quality and purity of these products vary considerably, and without regulatory oversight, buyers have limited assurance that what they receive matches what the label claims. Peptide impurities are a particular concern because even small contamination in a synthetic peptide can provoke immune reactions or other adverse effects that the pure compound would not.
The bottom line: BPC-157 is inspired by nature but made in a lab. Its amino acid sequence comes from a protein your stomach naturally produces, which gives it a biological pedigree that pure designer drugs lack. But the product people actually buy, inject, or swallow is a synthetic pharmaceutical with no approved human use and limited safety data.